GABELLI FUNDS LLC - DEPOMED INC ownership

DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 171 filers reported holding DEPOMED INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of DEPOMED INC
ValueSharesWeighting
Q1 2018$136,000
-48.1%
20,600
-36.8%
0.00%
-50.0%
Q4 2017$262,000
+17.5%
32,600
-15.5%
0.00%
+100.0%
Q3 2017$223,000
-88.6%
38,600
-78.8%
0.00%
-91.7%
Q2 2017$1,959,000
-29.0%
182,400
-17.1%
0.01%
-25.0%
Q1 2017$2,761,000
+350.4%
220,000
+547.1%
0.02%
+300.0%
Q4 2016$613,000
+145.2%
34,000
+240.0%
0.00%
+300.0%
Q3 2016$250,000
-15.0%
10,000
-33.3%
0.00%
-50.0%
Q2 2016$294,00015,0000.00%
Other shareholders
DEPOMED INC shareholders Q2 2018
NameSharesValueWeighting ↓
DELTEC ASSET MANAGEMENT LLC 1,876,195$42,045,0009.16%
Senvest Management, LLC 3,331,531$74,660,0004.62%
Krensavage Asset Management, LLC 343,546$7,699,0003.51%
PERKINS CAPITAL MANAGEMENT INC 97,950$2,195,0001.84%
HAYS ADVISORY LLC 580,069$12,999,0001.68%
ARBOR CAPITAL MANAGEMENT LLC 572,200$12,823,0001.54%
Broadfin Capital, LLC 705,204$15,804,0001.23%
EMERALD MUTUAL FUND ADVISERS TRUST 556,311$13,969,0001.14%
Pier Capital, LLC 330,682$7,411,0001.12%
TURNER INVESTMENTS LLC 259,357$5,812,0001.04%
View complete list of DEPOMED INC shareholders